Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends

Moghaddasi M., Oktay B., Bingol AB., Yanikoglu R., Muslu M., Ozbolat IT.

Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Adv Sci (Weinh) (2025)
Reported sample size
42
Source database
Europe PMC
PMID
40919670
PMCID
PMC12520499
DOI
10.1002/advs.202416085
Citations
18

Abstract (original English)

Conductive nanocomposite hydrogels (CNHs) represent a promising tool in neural tissue engineering, offering tailored electroactive microenvironments to address the complex challenges of neural repair. This systematic scoping review, conducted in accordance with PRISMA-ScR guidelines, synthesizes recent advancements in CNH design, functionality, and therapeutic efficacy for central and peripheral nervous system (CNS and PNS) applications. The analysis of 125 studies reveals a growing emphasis on multifunctional materials, with carbon-based nanomaterials (CNTs, graphene derivatives; 36.8%), metals (Iron oxides, gold, etc.; 24.0%), conductive polymers (PEDOT, PPy, etc.; 16.0%), and hybrid systems dominating due to their synergistic electrical, mechanical, and bioactive properties. For CNS repair, spinal cord injury models (n = 42) leverage antioxidant-conductive hybrids and immunomodulatory systems to mitigate oxidative stress and neuroinflammation. For PNS repair-particularly sciatic nerve regeneration (n = 20)-CNHs demonstrate efficacy through stimuli-responsive strategies (including wireless and self-powered piezoelectric and magnetic systems) and biomimetic scaffold design to guide axonal regeneration. Tailored hydrogel designs also address traumatic brain injury, stroke, and Parkinson's disease. Beyond these, CNHs show promise in diverse neural tissue engineering contexts, in

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
AnimalsHumansHydrogelsTissue EngineeringNerve RegenerationElectric ConductivityNanocomposites

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research